Literature DB >> 25878365

EPIDEMIOLOGICAL CONSEQUENCES OF IMPERFECT VACCINES FOR IMMUNIZING INFECTIONS.

F M G Magpantay1, M A Riolo2, M Domenech DE Cellès1, A A King3, P Rohani4.   

Abstract

The control of some childhood diseases has proven to be difficult even in countries that maintain high vaccination coverage. This may be due to the use of imperfect vaccines and there has been much discussion on the different modes by which vaccines might fail. To understand the epidemiological implications of some of these different modes, we performed a systematic analysis of a model based on the standard SIR equations with a vaccinated component that permits vaccine failure in degree ("leakiness"), take ("all-or-nothingness") and duration (waning of vaccine-derived immunity). The model was first considered as a system of ordinary differential equations, then extended to a system of partial differential equations to accommodate age structure. We derived analytic expressions for the steady states of the system and the final age distributions in the case of homogenous contact rates. The stability of these equilibria are determined by a threshold parameter Rp , a function of the vaccine failure parameters and the coverage p. The value of p for which Rp = 1 yields the critical vaccination ratio, a measure of herd immunity. Using this concept we can compare vaccines that confer the same level of herd immunity to the population but may fail at the individual level in different ways. For any fixed Rp > 1, the leaky model results in the highest prevalence of infection, while the all-or-nothing and waning models have the same steady state prevalence. The actual composition of a vaccine cannot be determined on the basis of steady state levels alone, however the distinctions can be made by looking at transient dynamics (such as after the onset of vaccination), the mean age of infection, the age distributions at steady state of the infected class, and the effect of age-specific contact rates.

Entities:  

Keywords:  age-structured population models; imperfect vaccines; infectious disease dynamics

Year:  2014        PMID: 25878365      PMCID: PMC4394665          DOI: 10.1137/140956695

Source DB:  PubMed          Journal:  SIAM J Appl Math        ISSN: 0036-1399            Impact factor:   2.080


  12 in total

1.  Realistic distributions of infectious periods in epidemic models: changing patterns of persistence and dynamics.

Authors:  A L Lloyd
Journal:  Theor Popul Biol       Date:  2001-08       Impact factor: 1.570

2.  On vaccine efficacy and reproduction numbers.

Authors:  C P Farrington
Journal:  Math Biosci       Date:  2003-09       Impact factor: 2.144

3.  Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives.

Authors:  M Gabriela M Gomes; Lisa J White; Graham F Medley
Journal:  J Theor Biol       Date:  2004-06-21       Impact factor: 2.691

4.  Implications of vaccination and waning immunity.

Authors:  J M Heffernan; M J Keeling
Journal:  Proc Biol Sci       Date:  2009-03-04       Impact factor: 5.349

5.  Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand.

Authors:  Julie C Blackwood; Derek A T Cummings; Hélène Broutin; Sopon Iamsirithaworn; Pejman Rohani
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-20       Impact factor: 11.205

6.  Threshold and stability results for an age-structured epidemic model.

Authors:  H Inaba
Journal:  J Math Biol       Date:  1990       Impact factor: 2.259

7.  Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies.

Authors:  P G Smith; L C Rodrigues; P E Fine
Journal:  Int J Epidemiol       Date:  1984-03       Impact factor: 7.196

8.  Imperfect vaccines and herd immunity to HIV.

Authors:  A R McLean; S M Blower
Journal:  Proc Biol Sci       Date:  1993-07-22       Impact factor: 5.349

9.  Interpretation and estimation of vaccine efficacy under heterogeneity.

Authors:  M E Halloran; M Haber; I M Longini
Journal:  Am J Epidemiol       Date:  1992-08-01       Impact factor: 4.897

10.  Immune boosting explains regime-shifts in prevaccine-era pertussis dynamics.

Authors:  Jennie S Lavine; Aaron A King; Viggo Andreasen; Ottar N Bjørnstad
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

View more
  22 in total

Review 1.  The pertussis enigma: reconciling epidemiology, immunology and evolution.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Proc Biol Sci       Date:  2016-01-13       Impact factor: 5.349

2.  Dynamics of Pertussis Transmission in the United States.

Authors:  F M G Magpantay; P Rohani
Journal:  Am J Epidemiol       Date:  2015-05-27       Impact factor: 4.897

3.  Vaccine impact in homogeneous and age-structured models.

Authors:  F M G Magpantay
Journal:  J Math Biol       Date:  2017-04-17       Impact factor: 2.259

4.  The impact of past vaccination coverage and immunity on pertussis resurgence.

Authors:  Matthieu Domenech de Cellès; Felicia M G Magpantay; Aaron A King; Pejman Rohani
Journal:  Sci Transl Med       Date:  2018-03-28       Impact factor: 17.956

5.  Core pertussis transmission groups in England and Wales: A tale of two eras.

Authors:  Ana I Bento; Maria A Riolo; Yoon H Choi; Aaron A King; Pejman Rohani
Journal:  Vaccine       Date:  2018-02-01       Impact factor: 3.641

6.  Pertussis immunity and epidemiology: mode and duration of vaccine-induced immunity.

Authors:  F M G Magpantay; M Domenech DE Cellès; P Rohani; A A King
Journal:  Parasitology       Date:  2015-09-04       Impact factor: 3.234

7.  Forecasting Epidemiological Consequences of Maternal Immunization.

Authors:  Ana I Bento; Pejman Rohani
Journal:  Clin Infect Dis       Date:  2016-12-01       Impact factor: 9.079

8.  Maternal pertussis immunisation: clinical gains and epidemiological legacy.

Authors:  Ana I Bento; Aaron A King; Pejman Rohani
Journal:  Euro Surveill       Date:  2017-04-13

9.  Prolonging herd immunity to cholera via vaccination: Accounting for human mobility and waning vaccine effects.

Authors:  Corey M Peak; Amanda L Reilly; Andrew S Azman; Caroline O Buckee
Journal:  PLoS Negl Trop Dis       Date:  2018-02-28

10.  Comparative performance of between-population vaccine allocation strategies with applications to SARS-CoV-2.

Authors:  Keya Joshi; Eva Rumpler; Lee Kennedy-Shaffer; Rafia Bosan; Marc Lipsitch
Journal:  medRxiv       Date:  2022-01-25
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.